The conference will have a careful and systematic review of the latest information, for example, data presented at rheumatology congresses; in particular, the annual meetings of the American College of Rheumatology (ACR), and the European League Against Rheumatism (EULAR). In order to accomplish this, we have assembled an outstanding faculty of superlative lecturers who have extensive expertise in these areas.

At the conclusion of this activity, participants should be able to:

*Differentiate methods of assessing outcomes for rheumatic diseases
*Evaluate and employ safety issues affecting rheumatic therapies
*Define and develop strategies when standard therapies fail
*Analyze and apply the latest data on SLE, PsA, AS, Gout and other conditions